Showing results (61-70 of 369) with videos related to
Sort By:
Pageof 37
Journal of Hematotherapy & Stem Cell Research|May 2, 2002
In vivo purging with rituximab prior to collection of stem cells for autologous transplantation in chronic lymphocytic leukemiaLeanne Berkahn, David Simpson, Anastasios Raptis, et al.Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cellsOlafur Eysteinn Sigurjónsson, Kristbjörn Orri Gudmundsson, Vilhelmína Haraldsdóttir, et al.Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Flow cytometric CD34+ determination in stem cell transplantation: before or after cryopreservation of grafts?T Fietz, B Reufi, C Mücke, et al.Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costsK R Meehan, E M Areman, S G Ericson, et al.Journal of Hematotherapy & Stem Cell Research|May 2, 2002
Quantitative and qualitative analysis of the human primitive progenitor cell compartment after autologous stem cell transplantationGuillaume Cartron, Olivier Herault, Lotfi Benboubker, et al.Journal of Hematotherapy & Stem Cell Research|August 28, 2001
Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8(+) T cellsY J Kim, H E BroxmeyerJournal of Hematotherapy & Stem Cell Research|January 14, 2000
Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1(low), c-kit+ stem cell lineC Lange, C Kaltz, K Thalmeier, et al.Journal of Hematotherapy & Stem Cell Research|January 14, 2000
Interleukine-8 acts as a strong peripheral blood granulocyte-recruiting agent rather than as a hematopoietic progenitor cell-mobilizing factorJ Vetillard, M Drouet, T M Neildez-Nguyen, et al.Journal of Hematotherapy & Stem Cell Research|January 14, 2000
The use of CD34+-selected PBPC after high-dose chemotherapy in breast cancer patients is associated with prolonged recovery time and increased infectious complicationsM Goerner, H Wandt, K Schäfer-Eckart, et al.Journal of Hematotherapy & Stem Cell Research|January 25, 2000
Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokinesL Qiu, R Meagher, S Welhausen, et al.Pageof 37